June 16, 2017
RARECast: Delivering Enzyme Replacement Therapies Across the Blood-Brain Barrier
Read More
September 3, 2016
ArmaGen Presents Data from First Cohort of Phase 1/2a of AGT-182 for Treatment of Hunter Syndrome
Read More
September 1, 2016
ArmaGen Announces Initiation of Phase 2 Proof-of-Concept Clinical Trial in Brazil to Study AGT-181 for Treatment of Hurler Syndrome
Read More
July 28, 2014
ArmaGen Announces Collaboration with Shire to Develop Treatment for Hunter Syndrome
Read More
X